These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2178480)

  • 41. Angiotensin converting enzyme inhibitors suppress the vascular renin-angiotensin system of spontaneously hypertensive rats.
    Higashimori K; Nakamaru M; Tabuchi Y; Nagano M; Mikami H; Ogihara T; Inagami T
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):56S-59S. PubMed ID: 2009150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system.
    Iyer SN; Ferrario CM; Chappell MC
    Hypertension; 1998 Jan; 31(1 Pt 2):356-61. PubMed ID: 9453328
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE?
    Schilders JE; Wu H; Boomsma F; van den Meiracker AH; Danser AH
    Cardiovasc Drugs Ther; 2014 Aug; 28(4):335-45. PubMed ID: 24958603
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic potential of renin inhibitors in the management of cardiovascular disorders.
    Stanton A
    Am J Cardiovasc Drugs; 2003; 3(6):389-94. PubMed ID: 14728059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Manipulations of the renin-angiotensin system and intake of a sweetened alcoholic beverage among rats.
    Hubbell CL; Chrisbacher GA; Bilsky EJ; Reid LD
    Alcohol; 1992; 9(1):53-61. PubMed ID: 1310248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antirenin immunization versus angiotensin converting enzyme inhibition in rats.
    Lo M; Julien C; Michel JB; Vincent M; Cerutti C; Gomez-Sanchez CE; Sassard J
    Hypertension; 1990 Jul; 16(1):80-8. PubMed ID: 2194942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
    Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE
    Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system.
    Säynävälammi P; Pörsti I
    Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New angiotensin converting enzyme inhibitors. Their role in the management of hypertension.
    Laragh JH
    Am J Hypertens; 1990 Nov; 3(11):257S-265S. PubMed ID: 2261144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors.
    Huang ML; Li X; Meng Y; Xiao B; Ma Q; Ying SS; Wu PS; Zhang ZS
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):e1-6. PubMed ID: 19793108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural adaptation to ischemia in skeletal muscle: effects of blockers of the renin-angiotensin system.
    Scheidegger KJ; Nelissen-Vrancken MH; Leenders PJ; Daemen MJ; Smits JF; Wood JM
    J Hypertens; 1997 Dec; 15(12 Pt 1):1455-62. PubMed ID: 9431852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Blockade of the renin-angiotensin system by a combination of ACE inhibitors and AT1 receptor antagonists].
    Azizi M
    Rev Prat; 2004 Jun; 54(11):1167-74. PubMed ID: 15496022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypertensive mechanisms and converting enzyme inhibitors.
    Ferrario CM; Jaiswal N; Yamamoto K; Diz DI; Schiavone MT
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV56-62; discussion IV83-90. PubMed ID: 1893643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
    van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
    J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin converting enzyme inhibitors and moderate hypertension.
    McAreavey D; Robertson JI
    Drugs; 1990 Sep; 40(3):326-45. PubMed ID: 2226219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulatory and extracirculatory effects of angiotensin-converting enzyme inhibition.
    Weber MA; Neutel JM; Smith DH
    Am Heart J; 1992 May; 123(5):1414-20. PubMed ID: 1575168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Renin-angiotensin system blocking drugs.
    Robles NR; Cerezo I; Hernandez-Gallego R
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):14-33. PubMed ID: 24038019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dietary Na and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats.
    Fox J; Guan S; Hymel AA; Navar LG
    Am J Physiol; 1992 May; 262(5 Pt 2):F902-9. PubMed ID: 1317125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The antihypertensive mechanism of delapril, a newly developed converting enzyme inhibitor, is related to the suppression of vascular angiotensin II release in the spontaneously hypertensive rat.
    Mizuno K; Tani M; Niimura S; Yamaguchi M; Inagami T; Fukuchi S
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):60S-66S. PubMed ID: 2009151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.